Contact: Cynthia M. Berger
Treasurer/CFO
Delphian Technology Inc.
781-935-8939
Delphian Technology Inc., a pioneer provider of fiber-optic analytical tools for pharmaceutical dissolution analysis, today announced it has exclusively developed the world’s first very-small volume dissolution apparatus, the µDISS™. Designed for use with Delphian Technology Inc.’s patented fiber optic dissolution monitoring systems, the µDISS handles volumes as small as 2 mL for intrinsic dissolution measurements on powders and for polymorph screening during scaling-up of compound production.
pION INC Offers Free Absorption and Dissolution Profiles
April 2003
Contact: Cynthia M. Berger
Treasurer/CFO
Delphian Technology Inc.
781-935-8939
pION INC, a leading provider of analytical tools for physicochemical profiling, today announced its “Molecule of the Month” program whereby visitors to www.pion-inc.com may download physicochemical data on known compounds. In association with its subsidiary, Delphian Technology Inc., visitors to www.delphian-tech.com can download “Profile of the Month” dissolution data on popular drug formulations. New compounds and drugs are added to the websites every month, beginning with Ciprofloxacin.HCl and Famotidine respectively...
pION INC Acquires Delphian Technology
in situ Fiber Optic Dissolution System
June 2002
Contact: Cynthia M. Berger
Treasurer/CFO
Delphian Technology Inc.
781-935-8939
David Richiger
Executive Director
Purdue Pharma L.P.
203-588-7203
pION INC, a leading provider of analytical tools for drug characteristic screening, today announced the acquisition of the of the Rainbow Dynamic Dissolution Monitor® System and related assets of Delphian Technology L.P. The purchase represents a major step forward for pION INC, by expanding their product lines to include assessment of physicochemical properties of drugs both in the early discovery phase and in the final manufacturing stage...
